Case report: Single infusion of combined anti-CD20 and anti-CD38 monoclonal antibodies in pediatric refractory lupus nephritis

Lupus nephritis (LN), present in 30%–50% of systemic lupus erythematosus (SLE) patients, often necessitates standard immunosuppressive therapy (glucocorticoids, MMF, CYC) as suggested by the European League Against Rheumatism/European Renal Association–European Dialysis and Transplant Association (E...

Повний опис

Збережено в:

Бібліографічні деталі
Автори:	Decimo Silvio Chiarenza, Raul Mancini, Carolina Bigatti, Gianluca Caridi, Alessandro Consolaro, Valentina Natoli, Gabriele Mortari, Xhuliana Kajana, Francesca Lugani, Marco Gattorno, Gian Marco Ghiggeri, Edoardo La Porta, Gabriele Gaggero, Enrico E. Verrina, Andrea Angeletti
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Frontiers Media S.A. 2025-01-01
Серія:	Frontiers in Immunology
Предмети:	systemic lupus erythematous lupus nephritis rituximab daratumumab monoclonal antibodies pediatric
Онлайн доступ:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1525892/full
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!

Case report: Single infusion of combined anti-CD20 and anti-CD38 monoclonal antibodies in pediatric refractory lupus nephritis

Схожі ресурси